Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 58

1.

NF-ATp, a T lymphocyte DNA-binding protein that is a target for calcineurin and immunosuppressive drugs.

McCaffrey PG, Perrino BA, Soderling TR, Rao A.

J Biol Chem. 1993 Feb 15;268(5):3747-52.

2.

Molecular mechanisms of immunosuppression by cyclosporine, FK506, and rapamycin.

Cardenas ME, Zhu D, Heitman J.

Curr Opin Nephrol Hypertens. 1995 Nov;4(6):472-7. Review.

PMID:
8591053
3.

Cyclosporin A, FK506 and rapamycin: more than just immunosuppression.

Kunz J, Hall MN.

Trends Biochem Sci. 1993 Sep;18(9):334-8. Review.

PMID:
7694398
4.

Biology of cyclosporin A and FK506.

Bierer BE.

Prog Clin Biol Res. 1994;390:203-23. Review. No abstract available.

PMID:
7536944
5.

Immunophilin-sensitive protein phosphatase action in cell signaling pathways.

Schreiber SL.

Cell. 1992 Aug 7;70(3):365-8. Review. No abstract available.

PMID:
1379518
6.

Three-dimensional structure and actions of immunosuppressants and their immunophilins.

Braun W, Kallen J, Mikol V, Walkinshaw MD, W├╝thrich K.

FASEB J. 1995 Jan;9(1):63-72. Review.

PMID:
7529736
7.

Inhibition of T-cell signaling pathways by immunophilin drug complexes: are side effects inherent to immunosuppressive properties?

Schreier MH, Baumann G, Zenke G.

Transplant Proc. 1993 Feb;25(1 Pt 1):502-7. Review. No abstract available.

PMID:
7679818
8.

Cyclosporin binding proteins. Identification, distribution, function and relation to FK binding proteins.

Ryffel B.

Biochem Pharmacol. 1993 Jul 6;46(1):1-12. Review. No abstract available.

PMID:
8394072
9.

FK-506 and cyclosporin A: immunosuppressive mechanism of action and beyond.

Siekierka JJ, Sigal NH.

Curr Opin Immunol. 1992 Oct;4(5):548-52. Review.

PMID:
1384551
10.

Some new aspects of molecular mechanisms of cyclosporin A effect on immune response.

Zav'yalov VP, Denesyuk AI, Lundell J, Korpela T.

APMIS. 1995 Jun;103(6):401-15. Review.

PMID:
7546642
11.

The antiparasite effects of cyclosporin A: possible drug targets and clinical applications.

Bell A, Roberts HC, Chappell LH.

Gen Pharmacol. 1996 Sep;27(6):963-71. Review.

PMID:
8909976
12.

Calcineurin: not just a simple protein phosphatase.

Guerini D.

Biochem Biophys Res Commun. 1997 Jun 18;235(2):271-5. Review.

PMID:
9199180
13.

Cyclosporin A, the cyclophilin class of peptidylprolyl isomerases, and blockade of T cell signal transduction.

Walsh CT, Zydowsky LD, McKeon FD.

J Biol Chem. 1992 Jul 5;267(19):13115-8. Review.

14.

Regulation of MAPK signaling pathways through immunophilin-ligand complex.

Matsuda S, Koyasu S.

Curr Top Med Chem. 2003;3(12):1358-67. Review.

PMID:
12871167
15.

The mechanism of action of FK-506 and cyclosporin A.

Wiederrecht G, Lam E, Hung S, Martin M, Sigal N.

Ann N Y Acad Sci. 1993 Nov 30;696:9-19. Review.

PMID:
7509138
16.

Proline isomerases at the crossroads of protein folding, signal transduction, and immunosuppression.

Heitman J, Movva NR, Hall MN.

New Biol. 1992 May;4(5):448-60. Review.

PMID:
1515410
17.

Recent advances in the mechanism of action of cyclosporine and FK506.

Tocci MJ, Sigal NH.

Curr Opin Nephrol Hypertens. 1992 Dec;1(2):236-42. Review.

PMID:
1285380
18.

Molecular mechanisms of new immunosuppressants.

Halloran PF.

Clin Transplant. 1996 Feb;10(1 Pt 2):118-23. Review.

PMID:
8680047
19.

Calcineurin-immunosuppressor complexes.

Stoddard BL, Flick KE.

Curr Opin Struct Biol. 1996 Dec;6(6):770-5. Review.

PMID:
8994877
20.

Sympathetic neural mechanisms of cyclosporine-induced hypertension.

Sander M, Lyson T, Thomas GD, Victor RG.

Am J Hypertens. 1996 Nov;9(11):121S-138S. Review.

PMID:
8931845

Supplemental Content

Support Center